JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2007; 50:2226-2232, doi:10.1016/j.jacc.2007.08.031 (Published online 14 November 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.08.031v1
50/23/2226    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hink, U.
Right arrow Articles by Munzel, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hink, U.
Right arrow Articles by Munzel, T.

CLINICAL RESEARCH: CARDIAC PHARMACOLOGY

Oxidative Inhibition of the Mitochondrial Aldehyde Dehydrogenase Promotes Nitroglycerin Tolerance in Human Blood Vessels

Ulrich Hink, MD*, Andreas Daiber, PhD*, Nalan Kayhan, MD{dagger}, Jordis Trischler, MS*, Catharina Kraatz, MS*, Matthias Oelze, PhD*, Hanke Mollnau, MD*, Philip Wenzel, MD*, Christian F. Vahl, MD{dagger}, Kwok Ki Ho, PhD{ddagger}, Henry Weiner, PhD{ddagger} and Thomas Munzel, MD*,*

* II Medizinische Klinik für Kardiologie und Angiologie, Johannes Gutenberg University, Mainz, Germany
{dagger} Klinik für Herz, Thorax und Gefäßchirurgie, Johannes Gutenberg University, Mainz, Germany
{ddagger} Purdue University, West Lafayette, Indiana.

Manuscript received October 13, 2006; revised manuscript received July 10, 2007, accepted August 16, 2007.

* Reprint requests and correspondence: Dr. Thomas Münzel, II Medizinische Klinik und Poliklinik, Johannes Gutenberg Universität Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany. (Email: tmuenzel{at}uni-mainz.de).

Objectives: We tested the hypothesis of whether an inhibition of the nitroglycerin (GTN) bioactivating enzyme mitochondrial aldehyde dehydrogenase (ALDH-2) contributes to GTN tolerance in human blood vessels.

Background: The hemodynamic effects of GTN are rapidly blunted by the development of tolerance, a phenomenon associated with increased formation of reactive oxygen species (ROS). Recent studies suggest that ROS-induced inhibition of ALDH-2 accounts for tolerance in animal models.

Methods: Segments of surgically removed arteria mammaria and vena saphena from patients undergoing coronary bypass surgery were used to examine the vascular responsiveness to GTN and the endothelium-dependent vasodilator acetylcholine. The ALDH-2 activity and expression in these segments were assessed by the conversion of a benzaldehyde or its derivative to the benzoic acid metabolite and by Western blotting technique.

Results: In contrast to patients not treated with nitrates (n = 36), patients treated with GTN for 48 h (n = 14) before surgery showed tolerance to GTN and endothelial dysfunction in arterial and venous vessels. In vivo GTN tolerance was mimicked in vitro by incubation of nontolerant vessels with the ALDH-2 inhibitor benomyl. In vivo GTN treatment decreased vascular aldehyde dehydrogenase activity compared with nontolerant vessels and decreased the expression of ALDH-2 in arterial tissue. Incubation of control venous vessels with GTN caused a significant attenuation of aldehyde dehydrogenase activity that was reversed by presence of the sulfhydryl group donor dithiothreitol.

Conclusions: Long-term GTN treatment induces tolerance and endothelial dysfunction in human vessels, associated with an inhibition and down-regulation of vascular ALDH-2. Thus, these findings extend results of previous animal studies to humans.

Abbreviations and Acronyms
  ALDH-2 = mitochondrial aldehyde dehydrogenase
  DTT = dithiothreitol
  EC50 = half-maximal concentration
  eNOS = endothelial nitric oxide synthase
  GTN = glycerol trinitrate, nitroglycerin
  ROS = reactive oxygen species




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
R. Guo, X.-P. Chen, X. Guo, L. Chen, D. Li, J. Peng, and Y.-J. Li
Evidence for Involvement of Calcitonin Gene-Related Peptide in Nitroglycerin Response and Association With Mitochondrial Aldehyde Dehydrogenase-2 (ALDH2) Glu504Lys Polymorphism
J. Am. Coll. Cardiol., September 9, 2008; 52(11): 953 - 960.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
U. Hink, M.-S. S. Alhamdani, and T. Munzel
Nitroglycerin Hits the Nerve: Role for Mitochondrial Aldehyde Dehydrogenase?
J. Am. Coll. Cardiol., September 9, 2008; 52(11): 961 - 963.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2007 by the American College of Cardiology Foundation.